Sentry is a real-time, explainable risk intelligence platform designed to protect the U.S. pharmaceutical supply chain from counterfeit drugs. It fuses multi-agency, trade, and open-source data to evaluate every inbound shipment, enriches records with live signals, and generates an auditable risk score with top reasons for concern. By flagging high-risk shipments before clearance, Sentry enables targeted inspections that prevent dangerous counterfeit drugs from entering the country.
Challenge
The U.S. pharmaceutical supply chain is increasingly vulnerable to counterfeit infiltration, illicit trade networks, and foreign adversarial exploitation. Agencies need scalable, explainable, data-fusion capabilities to detect high-risk shipments across ports of entry before clearance. Without proactive risk intelligence, counterfeit drugs may enter domestic distribution channels, threatening patient safety and undermining national supply chain resilience. Strategic risk areas include:
- Trans-shipment masking true country of origin
- Shell importers and newly formed entities
- Supply chain diversion through free trade zones
- Limited interagency data harmonization
Our Solution
To address the growing complexity and scale of counterfeit threats, agencies need more than fragmented data and reactive enforcement, they need real-time, actionable intelligence that can be trusted in the field. Precise developed Sentry to deliver a unified, explainable platform that transforms disparate signals into clear, shipment-level risk insights, enabling faster, more precise decisions at the border.
- Predictive Risk Scoring at the Shipment Level
Every inbound package is dynamically scored for counterfeit drug risk, with updates as new data (recalls, alerts, enforcement actions) is received. - Data Fusion for Pharma Integrity
Integrates data across FDA, CBP, DEA, Interpol, WHO, and commercial/watchlist sources. Resolves product, manufacturer, domain, route, and lot to spot inconsistencies or fraud patterns. - Explainable AI for Enforcement Trust
Each score comes with “top reasons” in plain language (e.g., prior seizure history, import alert, suspicious seller domain, diversion risk), ensuring transparency for officers and auditors. - Targeted Triage to Optimize Resources
High-risk shipments are automatically flagged for inspection, while legitimate goods are cleared faster—balancing safety with trade efficiency. - Secure, Auditable Oversight
All data, scores, and enforcement actions are logged with lineage for compliance, audit, and review. - Operational Tools for the Field
- Pipeline Studio: visualize enrichment stages.
- Graph Explorer: uncover hidden supplier or route networks linked to counterfeit activity.
- AI Assistant: one-click queries for officers in the field.
Impact
- Protects Public Health: Stops counterfeit drugs at the border before they reach pharmacies, hospitals, or patients.
- Increases Enforcement Effectiveness: Predictive targeting raises the yield of inspections without increasing staff or workload.
- Reduces Downstream Burden: Prevents distribution, recalls, and investigations that would otherwise fall to regulators and healthcare systems.
- Strengthens Supply Chain Integrity: Enhances confidence for legitimate manufacturers, distributors, and consumers in the safety of U.S. drug imports.
- Supports Interagency Coordination: Provides a single signal detection layer that agencies can act on consistently.
